Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Biosci Rep ; 43(10)2023 10 31.
Artículo en Inglés | MEDLINE | ID: mdl-37728310

RESUMEN

DNA replication forks are subject to intricate surveillance and strict regulation by sophisticated cellular machinery. Such close regulation is necessary to ensure the accurate duplication of genetic information and to tackle the diverse endogenous and exogenous stresses that impede this process. Stalled replication forks are vulnerable to collapse, which is a major cause of genomic instability and carcinogenesis. Replication stress responses, which are organized via a series of coordinated molecular events, stabilize stalled replication forks and carry out fork reversal and restoration. DNA damage tolerance and repair pathways such as homologous recombination and Fanconi anemia also contribute to replication fork stabilization. The signaling network that mediates the transduction and interplay of these pathways is regulated by a series of post-translational modifications, including ubiquitination, which affects the activity, stability, and interactome of substrates. In particular, the ubiquitination of replication protein A and proliferating cell nuclear antigen at stalled replication forks promotes the recruitment of downstream regulators. In this review, we describe the ubiquitination-mediated signaling cascades that regulate replication fork progression and stabilization. In addition, we discuss the targeting of replication fork stability and ubiquitination system components as a potential therapeutic approach for the treatment of cancer.


Asunto(s)
Replicación del ADN , Neoplasias , Humanos , Replicación del ADN/genética , Ubiquitinación , Daño del ADN , Inestabilidad Genómica , Recombinación Homóloga , Neoplasias/genética , Neoplasias/terapia
2.
Heliyon ; 9(3): e13587, 2023 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-36851959

RESUMEN

A simple solid phase extraction (SPE) coupled with spectrophotometric method was developed for determination of trace permanganate (MnO4 -) in water. Commercial reagent polyamined-6 powder was used as SPE stationary phase to retain MnO4 - which is based on the fact that MnO4 - can be adsorbed on polyamide 6 (PA-6) sorbent as water samples flow through the SPE cartridge. 3,3',5,5'-tetramethylbenzidine (TMB) were used both as eluent solution and chromogenic agent to convert the adsorbed MnO4 - into Mn2+ and generate blue oxidized product with high molar absorptivity. Quantification of MnO4 - could be obtained by spectrophotometric detection of the resulting solution flow out of the SPE cartridge. The extraction and detection variables was optimized to maximize the absorbance of the TMB oxidized product. Under optimized conditions, this method provided linear dynamic ranges of 0.01-1 µmol L-1 for MnO4 - with preconcentration of 100 mL water sample. The limits of detection (3Sb/m) of this method in deionized water were calculated to be 5.1 nM, and the relative standard deviations were determined to be 3.2% (C = 0.1 µmol L-1, n = 5). This method has been applied to the determination of MnO4 - in spiked tap waters and satisfactory recovery was obtained.

3.
Microb Cell Fact ; 21(1): 38, 2022 Mar 12.
Artículo en Inglés | MEDLINE | ID: mdl-35279161

RESUMEN

BACKGROUND: Lytic polysaccharide monooxygenases (LPMOs) belonging to the auxiliary activity 9 family (AA9) are widely found in aerobic fungi. These enzymes are O2-dependent copper oxidoreductases that catalyze the oxidative cleavage of cellulose. However, studies that have investigated AA9 LPMOs of aerobic fungi in the herbivore gut are scare. To date, whether oxidative cleavage of cellulose occurs in the herbivore gut is unknown. RESULTS: We report for the first time experimental evidence that AA9 LPMOs from aerobic thermophilic fungi catalyze the oxidative cleavage of cellulose present in the horse gut to C1-oxidized cellulose and C1- and C4-oxidized cello-oligosaccharides. We isolated and identified three thermophilic fungi and measured their growth and AA9 LPMO expression at 37 °C in vitro. We also assessed the expression and the presence of AA9 LPMOs from thermophilic fungi in situ. Finally, we used two recombinant AA9 LPMOs and a native AA9 LPMO from thermophilic fungi to cleave cellulose to yield C1-oxidized products at 37 °C in vitro. CONCLUSIONS: The oxidative cleavage of cellulose occurs in the horse gut. This finding will broaden the known the biological functions of the ubiquitous LPMOs and aid in determining biological significance of aerobic thermophilic fungi.


Asunto(s)
Celulosa , Oxigenasas de Función Mixta , Animales , Celulosa/metabolismo , Caballos , Oxigenasas de Función Mixta/metabolismo , Estrés Oxidativo , Oxidorreductasas/metabolismo , Polisacáridos/metabolismo
5.
Nanoscale ; 13(25): 11004-11016, 2021 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-34136895

RESUMEN

Zinc ion hybrid supercapacitors (ZICs) are truly promising competitors in prospective extensive electrochemical energy storage fields due to their cost-effectiveness, environmentally friendly nature, inherent security, and satisfying gravimetric energy density. Thus, several investigation endeavors have been dedicated to the construction and exploitation of high-performance ZICs. However, the exploitation of ZICs is still in its preliminary stage and there are many problems that need to be overcome before their potential can be fully realized. Recently, 2D materials with a fascinating structure and intriguing features have attracted enormous attention for applications in ZICs with prominent improvement from charge storage capacity to reaction kinetics. In this article, the recent research progress in 2D materials and their composites in the pursuit of high-performance ZICs is systematically reviewed, focusing on the possible charge storage mechanism of ZICs. In addition, the influence of the structure of 2D materials and their composites on the electrochemical performance and the zinc ion storage mechanism is analyzed. Finally, the challenges and prospects of the application of 2D materials and their composites in high-performance ZICs are presented.

6.
Rev Sci Instrum ; 91(1): 014710, 2020 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-32012550

RESUMEN

This paper proposes a method to measure the frequency of terahertz (THz) waves based on the Zeeman effect and the high magnetic field technology with a wideband range from 60 GHz to 3 THz. As the frequency of THz waves absorbed by the sample is linear to the magnetic field in the Zeeman effect, the frequency can be measured by the magnetic field strength. A comparison study of THz frequency measurement was carried out in two magnet systems (a superconducting one and a pulsed one) to investigate the performance in two kinds of high magnetic fields. The experimental results of 60-700 GHz show that this method has high resolution (about 0.001%), excellent linearity, and good repeatability. Moreover, the proposed method can measure polychromatic signals simultaneously as well as the single pulse frequency in the order of tens of microseconds.

7.
Aerosp Med Hum Perform ; 89(10): 883-888, 2018 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-30219115

RESUMEN

BACKGROUND: Skeletal muscle atrophy is a striking example of the multiple changes in the physiological state of humans and animals induced by microgravity. Previous studies have shown that a blood circulation disorder may be a cause of this atrophy, and traditional Chinese medicine has been regarded as a potential countermeasure to reverse the atrophy in China. This study was carried out to test the effects of Xuefuzhuyu capsules (XFZY) on the skeletal muscle atrophy induced by simulated microgravity. METHODS: The mass and cross-sectional area of the soleus muscle were compared in rats treated with XFZY that were hindlimb unloaded for 30 d (XFZY-TS group), untreated rats that were hindlimb unloaded for 30 d (TS group), and control rats (CON group). The expression and phosphorylation levels of key proteins of the sarcoplasmic reticulum stress system were also measured. RESULTS: Treatment with XFZY attenuated the loss of muscle mass and cross-sectional area induced by hindlimb unloading. Western blot analysis showed that the phosphatidyl-inositol-3-kinase/phospho-Akt (PI3K/p-Akt) pathways were down-regulated after 30 d in the TS group compared with the CON group. This effect was partly reversed by XFZY. Hindlimb unloading increased the expression of glucose-regulated protein 78 (GRP78), cytosine-cytosine-adenosine-adenosine-thymidine/enhancer-binding protein homologous protein (CHOP), C-Jun N-terminal kinase (JNK), and Caspase 12. Treatment with XFZY alleviated this increased protein expression. DISCUSSION: Our results suggest that XFZY could partially reverse the effects of hindlimb unloading on muscle atrophy and perhaps target the sarcoplasmic reticulum stress system, possibly through the GRP78-CHOP-JNK-Caspase 12 pathway.Zhang S, Yuan M, Cheng C, Xia D, Wu S. Chinese herbal medicine effects on muscle atrophy induced by simulated microgravity. Aerosp Med Hum Perform. 2018; 89(10):883-888.


Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Suspensión Trasera , Músculo Esquelético/efectos de los fármacos , Atrofia Muscular/patología , Simulación de Ingravidez , Animales , Caspasa 12/efectos de los fármacos , Caspasa 12/metabolismo , Chaperón BiP del Retículo Endoplásmico , Proteínas de Choque Térmico/efectos de los fármacos , Proteínas de Choque Térmico/metabolismo , Proteínas Quinasas JNK Activadas por Mitógenos/efectos de los fármacos , Proteínas Quinasas JNK Activadas por Mitógenos/metabolismo , Sistema de Señalización de MAP Quinasas , Masculino , Músculo Esquelético/metabolismo , Músculo Esquelético/patología , Atrofia Muscular/metabolismo , Fosfatidilinositol 3-Quinasa/efectos de los fármacos , Fosfatidilinositol 3-Quinasa/metabolismo , Fosforilación/efectos de los fármacos , Proteínas Proto-Oncogénicas c-akt/efectos de los fármacos , Proteínas Proto-Oncogénicas c-akt/metabolismo , Ratas , Ratas Sprague-Dawley , Transducción de Señal , Factor de Transcripción CHOP/efectos de los fármacos , Factor de Transcripción CHOP/metabolismo
8.
Cell Rep ; 10(2): 239-52, 2015 Jan 13.
Artículo en Inglés | MEDLINE | ID: mdl-25558064

RESUMEN

The balance and distribution of epithelial cell types is required to maintain tissue homeostasis. A hallmark of airway diseases is epithelial remodeling, leading to increased goblet cell numbers and an overproduction of mucus. In the conducting airway, basal cells act as progenitors for both secretory and ciliated cells. To identify mechanisms regulating basal cell fate, we developed a screenable 3D culture system of airway epithelial morphogenesis. We performed a high-throughput screen using a collection of secreted proteins and identified inflammatory cytokines that specifically biased basal cell differentiation toward a goblet cell fate, culminating in enhanced mucus production. We also demonstrate a specific requirement for Notch2 in cytokine-induced goblet cell metaplasia in vitro and in vivo. We conclude that inhibition of Notch2 prevents goblet cell metaplasia induced by a broad range of stimuli and propose Notch2 neutralization as a therapeutic strategy for preventing goblet cell metaplasia in airway diseases.


Asunto(s)
Citocinas/farmacología , Células Caliciformes/efectos de los fármacos , Pulmón/patología , Receptor Notch2/metabolismo , Animales , Técnicas de Cultivo de Célula , Diferenciación Celular/efectos de los fármacos , Células Cultivadas , Citocinas/genética , Citocinas/metabolismo , Modelos Animales de Enfermedad , Células Epiteliales/citología , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Femenino , Células Caliciformes/citología , Células Caliciformes/metabolismo , Factor Nuclear 3-gamma del Hepatocito/genética , Factor Nuclear 3-gamma del Hepatocito/metabolismo , Humanos , Interleucina-13/genética , Interleucina-13/metabolismo , Interleucina-13/farmacología , Interleucina-17/genética , Interleucina-17/metabolismo , Interleucina-17/farmacología , Pulmón/metabolismo , Metaplasia , Ratones , Ratones Endogámicos BALB C , Mucina 5AC/genética , Mucina 5AC/metabolismo , Mucina 5B/genética , Mucina 5B/metabolismo , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/genética , Proteínas Recombinantes/farmacología
9.
J Lipid Res ; 50(8): 1581-8, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19060325

RESUMEN

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is predominantly expressed in liver and regulates cholesterol metabolism by down regulating liver LDL receptor (LDLR) proteins. Here we report transgenic overexpression of human PCSK9 in kidney increased plasma levels of PCSK9 and subsequently led to a dramatic reduction in liver LDLR proteins. The regulation of LDLR by PCSK9 displayed tissue specificity, with liver being the most responsive tissue. Even though the PCSK9 transgene was highly expressed in kidney, LDLR proteins were suppressed to a lower extent in this tissue than in liver. Adrenal LDLR proteins were not regulated by elevated plasma PCSK9. hPCSK9 transgene expression and subsequent reduction of liver LDLR led to increases in plasma total cholesterol, LDL cholesterol, and ApoB, which were further increased by a high-fat, high-cholesterol diet. We also observed that the size distribution of hPCSK9 in transgenic mouse plasma was heterogeneous. In chow-fed mice, the majority of PCSK9 proteins were in free forms; however, feeding a high-fat, high-cholesterol diet resulted in a shift of hPCSK9 distribution toward larger complexes. PCSK9 distribution in human plasma also exhibited heterogeneity and individual variability in the percentage of PCSK9 in free form and in large complexes. We provide strong evidence to support that human PCSK9 proteins secreted from extrahepatic tissue are able to promote LDLR degradation in liver and increase plasma LDL. Our data also suggest that LDLR protein regulation by PCSK9 has tissue specificity, with liver being the most responsive tissue.


Asunto(s)
Lipoproteínas/sangre , Hígado/metabolismo , Receptores de LDL/metabolismo , Serina Endopeptidasas/fisiología , Glándulas Suprarrenales/metabolismo , Animales , Apolipoproteínas B/sangre , Colesterol/análisis , Colesterol/sangre , Colesterol en la Dieta/metabolismo , HDL-Colesterol/sangre , LDL-Colesterol/sangre , VLDL-Colesterol/sangre , Grasas de la Dieta/metabolismo , Femenino , Regulación de la Expresión Génica , Humanos , Riñón/química , Riñón/enzimología , Riñón/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Especificidad de Órganos , Proproteína Convertasa 9 , Proproteína Convertasas , Serina Endopeptidasas/sangre , Serina Endopeptidasas/genética , Serina Endopeptidasas/metabolismo , Triglicéridos/análisis
10.
J Pharmacol Exp Ther ; 326(3): 801-8, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18577702

RESUMEN

Sterol regulatory element-binding proteins (SREBPs) are major transcriptional regulators of cholesterol, fatty acid, and glucose metabolism. Genetic disruption of SREBP activity reduces plasma and liver levels of cholesterol and triglycerides and insulin-stimulated lipogenesis, suggesting that SREBP is a viable target for pharmacological intervention. The proprotein convertase SREBP site 1 protease (S1P) is an important posttranscriptional regulator of SREBP activation. This report demonstrates that 10 microM PF-429242 (Bioorg Med Chem Lett 17:4411-4414, 2007), a recently described reversible, competitive aminopyrrolidineamide inhibitor of S1P, inhibits endogenous SREBP processing in Chinese hamster ovary cells. The same compound also down-regulates the signal from an SRE-luciferase reporter gene in human embryonic kidney 293 cells and the expression of endogenous SREBP target genes in cultured HepG2 cells. In HepG2 cells, PF-429242 inhibited cholesterol synthesis, with an IC(50) of 0.5 microM. In mice treated with PF-429242 for 24 h, the expression of hepatic SREBP target genes was suppressed, and the hepatic rates of cholesterol and fatty acid synthesis were reduced. Taken together, these data establish that small-molecule S1P inhibitors are capable of reducing cholesterol and fatty acid synthesis in vivo and, therefore, represent a potential new class of therapeutic agents for dyslipidemia and for a variety of cardiometabolic risk factors associated with diabetes, obesity, and the metabolic syndrome.


Asunto(s)
Regulación Enzimológica de la Expresión Génica/fisiología , Lipogénesis/fisiología , Proproteína Convertasas/antagonistas & inhibidores , Inhibidores de Proteasas/farmacología , Procesamiento Proteico-Postraduccional/efectos de los fármacos , Proteínas de Unión a los Elementos Reguladores de Esteroles/antagonistas & inhibidores , Proteínas de Unión a los Elementos Reguladores de Esteroles/metabolismo , Animales , Células CHO , Línea Celular , Células Cultivadas , Cricetinae , Cricetulus , Relación Dosis-Respuesta a Droga , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Humanos , Lipogénesis/efectos de los fármacos , Masculino , Ratones , Proproteína Convertasas/genética , Proproteína Convertasas/metabolismo , Inhibidores de Proteasas/química , Serina Endopeptidasas/genética , Serina Endopeptidasas/metabolismo , Proteínas de Unión a los Elementos Reguladores de Esteroles/biosíntesis
11.
Nat Struct Mol Biol ; 14(5): 413-9, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17435765

RESUMEN

Proprotein convertase subtilisin kexin type 9 (PCSK9) lowers the abundance of surface low-density lipoprotein (LDL) receptor through an undefined mechanism. The structure of human PCSK9 shows the subtilisin-like catalytic site blocked by the prodomain in a noncovalent complex and inaccessible to exogenous ligands, and that the C-terminal domain has a novel fold. Biosensor studies show that PCSK9 binds the extracellular domain of LDL receptor with K(d) = 170 nM at the neutral pH of plasma, but with a K(d) as low as 1 nM at the acidic pH of endosomes. The D374Y gain-of-function mutant, associated with hypercholesterolemia and early-onset cardiovascular disease, binds the receptor 25 times more tightly than wild-type PCSK9 at neutral pH and remains exclusively in a high-affinity complex at the acidic pH. PCSK9 may diminish LDL receptors by a mechanism that requires direct binding but not necessarily receptor proteolysis.


Asunto(s)
Hipercolesterolemia/genética , Mutación Missense/fisiología , Serina Endopeptidasas/metabolismo , Sitios de Unión , Humanos , Concentración de Iones de Hidrógeno , Hipercolesterolemia/etiología , Proproteína Convertasa 9 , Proproteína Convertasas , Unión Proteica/genética , Conformación Proteica , Receptores de LDL/metabolismo , Serina Endopeptidasas/química , Serina Endopeptidasas/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...